Selective estrogen receptor modulators

Details for Australian Patent Application No. 2002326590 (hide)

Owner Merck & Co., Inc.

Inventors Ratcliffe, Ronald, W.; Meng, Dongfang; Parker, Dann, LeRoy, Jr.; Wilkening, Robert, R.

Agent Spruson & Ferguson

Pub. Number AU-B-2002326590

PCT Number PCT/US02/25377

PCT Pub. Number WO2003/015761

Priority 60/311,925 13.08.01 US

Filing date 9 August 2002

Wipo publication date 3 March 2003

Acceptance publication date 8 March 2007

International Classifications

C07D 295/08 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/136 (2006.01) - having the amino group directly attached to the aromatic ring, e.g. benzeneamine

A61K 31/277 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 5/30 (2006.01) Drugs for disorders of the endocrine system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/06 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 211/42 (2006.01) Compounds containing amino groups bound to a carbon skeleton

C07C 225/22 Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a CHO group, e.g. amino ketones

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 60/311,925 13.08.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002326590

8 March 2007 Application Accepted

  Published as AU-B-2002326590

5 July 2007 Standard Patent Sealed

4 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002326591-TOOLS AND TECHNIQUES FOR READER-GUIDED INCREMENTAL IMMERSION IN A FOREIGN LANGUAGE TEXT

2002326589-Compositions and methods for the prevention and treatment of Huntington's disease